Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Malcolm Spicer

Malcolm Spicer, Managing Editor – US

Washington, DC
Malcolm Spicer is lead analyst for Pharma intelligence | informa's coverage of the consumer health care products industries. He provides comprehensive and insightful reporting on manufacturing, marketing, regulation, legislation, financial and research news about the nonprescription drug and nutritional product industries. He has worked in this post for 10 years and previously reported for other publications on regulation of the health care industry, on the telecommunications and internet technologies and on the US energy market.

Latest From Malcolm Spicer

Sales Grow Across C&D's Products And Regions, But Increasing Supply Costs Stunt Income

Raw material supplies slowed during January-March period by catastrophic freeze in Texas and shortage of shipping containers partly due to Suez Canal blockage. "We're absorbing $90 million of incremental costs for the full year,” says CFO Ronald Dierker.

Dietary Supplements Sales & Earnings

Trade Groups Push US FDA To Close Window On Loosened OTC Sanitizer Production Standards

A day after FDA posted Scentsational’s recall announcement due to presence of benzene and acetaldehyde as well as methanol, American Cleaning Institute and Consumer Healthcare Products Association submit a letter urging FDA to restore order to OTC alcohol-based sanitizer market.

FDA Guidance Documents

Sanofi Returning Zantac OTC Heartburn Remedy Brand To US Market Formulated With Famotidine

Along with its Q1 results including a 7.3% drop in consumer health sales to 1.11bn ($1.35bn), Sanofi announces 10-mg famotidine tablets branded Zantac 360° will be available in the US in June.

OTC Drugs Launches

Binx STI Test Kits Move From POC To At-Home Through Walgreens

Binx Health's collection kits include tests for chlamydia, gonorrhea, syphilis, HIV, HPV and other common sexually transmitted infections, which may have accelerated because COVID-19 pandemic “has greatly affected access to in-person STI testing."

Retail OTC Devices

DTC Men’s Health Product Brand Roman Reaches In-Store Sales With Supplements Sold At Walmart

A month after closing its largest funding round, Roman Health' says its daily vitamins and supplements for heart health, stress relief, testosterone support, prostate health and a multivitamin will be available in Walmart stores and in the retail giant’s e-commerce platform on 1 May.

Dietary Supplements E-Commerce

Sun Pharma US Business Co-packages OTC Emergency Contraceptive With Pregnancy Test

My After Plan has been available online and in stores since October 2020, shortly before Sun Pharma received registration for the trademark in the US. Recently, marketing and design consultants announced their work for Sun Pharma's Ohm Labs on My After Plan packaging.

Advertising, Marketing & Sales OTC Drugs
See All
UsernamePublicRestriction

Register